Last reviewed · How we verify

secretin, biologically derived porcine

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Phase 3 active Small molecule

secretin, biologically derived porcine is a hormone Small molecule drug developed by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). It is currently in Phase 3 development for Treatment of pancreatic fistula.

Secretin is a hormone that stimulates the pancreas to release digestive enzymes and bicarbonate.

Secretin, a biologically derived porcine drug, has been evaluated in a Phase 3 trial for autism but lacks FDA approval. It is not commercially available and has no current revenue. The drug's mechanism involves regulating gastrointestinal functions, but its efficacy in autism remains inconclusive.

At a glance

Generic namesecretin, biologically derived porcine
SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Drug classhormone
Targetsecretin receptor
ModalitySmall molecule
Therapeutic areaGastroenterology
PhasePhase 3

Mechanism of action

Secretin works by binding to secretin receptors on the surface of pancreatic acinar cells, which triggers a signaling cascade that leads to the release of digestive enzymes and bicarbonate into the small intestine. This helps to neutralize stomach acid and facilitate the digestion of nutrients.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about secretin, biologically derived porcine

What is secretin, biologically derived porcine?

secretin, biologically derived porcine is a hormone drug developed by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), indicated for Treatment of pancreatic fistula.

How does secretin, biologically derived porcine work?

Secretin is a hormone that stimulates the pancreas to release digestive enzymes and bicarbonate.

What is secretin, biologically derived porcine used for?

secretin, biologically derived porcine is indicated for Treatment of pancreatic fistula.

Who makes secretin, biologically derived porcine?

secretin, biologically derived porcine is developed by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (see full Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline at /company/eunice-kennedy-shriver-national-institute-of-child-health-and-human-development).

What drug class is secretin, biologically derived porcine in?

secretin, biologically derived porcine belongs to the hormone class. See all hormone drugs at /class/hormone.

What development phase is secretin, biologically derived porcine in?

secretin, biologically derived porcine is in Phase 3.

What are the side effects of secretin, biologically derived porcine?

Common side effects of secretin, biologically derived porcine include Nausea, Vomiting, Diarrhea.

What does secretin, biologically derived porcine target?

secretin, biologically derived porcine targets secretin receptor and is a hormone.

Related